檢索結果 - Max Mastall
- Showing 1 - 2 results of 2
-
1
A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: t... 由 Max Mastall, Patrick Roth, Andrea Bink, Angela Fischer Maranta, Heinz Läubli, Andreas F. Hottinger, Thomas Hundsberger, Denis Migliorini, Adrian F. Ochsenbein, Katharina Seystahl, Lukas L. Imbach, Tibor Hortobágyi, Leonhard Held, Michael Weller, Hans‐Georg Wirsching
出版 2024Artigo -
2
Expression of PD-1 by T Cells in Malignant Glioma Patients Reflects Exhaustion and Activation 由 Tom B. Davidson, Alex Lee, Melody S. Hsu, Shaina Sedighim, Joey Orpilla, Janet Treger, Max Mastall, Saskia Roesch, Carmen Rapp, Mildred Galvez, Aaron Mochizuki, Joseph Antonios, Alejandro J. Garcia, Nikesh Kotecha, Nicholas Bayless, David A. Nathanson, Anthony Wang, Richard G. Everson, William H. Yong, Timothy F. Cloughesy, Linda M. Liau, Christel Herold‐Mende, Robert M. Prins
出版 2018Artigo
相關主題
Biology
Cancer research
Medicine
Antigen
Biochemistry
Chemoradiotherapy
Cytotoxic T cell
Drug
Drug repositioning
Ecology
Environmental health
Glioblastoma
Glioma
Immune system
Immunology
Immunotherapy
In vitro
Internal medicine
Oncology
Open label
Overall survival
Pharmacology
Population
Randomized controlled trial
Repurposing
Surgical oncology
T cell